Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Pathophysiol. Aug 15, 2014; 5(3): 133-146
Published online Aug 15, 2014. doi: 10.4291/wjgp.v5.i3.133
Role of Toll-like receptors in Helicobacter pylori infection and immunity
Sinéad M Smith
Sinéad M Smith, Department of Clinical Medicine, Trinity Centre, Adelaide and Meath Hospital, Dublin 24, Ireland
Sinéad M Smith, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland
Author contributions: Smith SM reviewed the literature, drafted and wrote the manuscript.
Correspondence to: Sinéad Smith, PhD, Assistant Professor in Applied and Translational Medicine, Department of Clinical Medicine, Trinity Centre, Adelaide and Meath Hospital, Room 1.44, Tallaght, Dublin 24, Ireland. smithsi@tcd.ie
Telephone: +353-1-8962998 Fax: +353-1-8962988
Received: January 21, 2014
Revised: February 25, 2014
Accepted: May 16, 2014
Published online: August 15, 2014
Core Tip

Core tip: Eradication rates for Helicobacter pylori (H. pylori) infection have fallen. The development of therapeutic alternatives to antibiotics, such as immunomodulatory therapy and vaccines requires a clearer understanding of host-pathogen interactions. As Toll-like receptors are intimately involved in the regulation of inflammation in response to H. pylori and represent key activators of adaptive immunity, they represent a target for therapeutic manipulation. Elucidating innate immune signals triggered by H. pylori will provide an understanding of how the balance between pro-inflammatory and anti-inflammatory signals fine-tunes the response to infection and insight into how the immune response may be manipulated therapeutically to successfully eradicate the bacterium.